Concepts (188)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Early Detection of Cancer | 7 | 2025 | 418 | 2.150 |
Why?
|
| Neoplastic Syndromes, Hereditary | 5 | 2025 | 81 | 1.900 |
Why?
|
| von Hippel-Lindau Disease | 3 | 2025 | 17 | 1.640 |
Why?
|
| Paraganglioma | 2 | 2025 | 22 | 1.450 |
Why?
|
| Pheochromocytoma | 2 | 2025 | 38 | 1.440 |
Why?
|
| Adrenal Gland Neoplasms | 2 | 2025 | 78 | 1.370 |
Why?
|
| Jaw Neoplasms | 2 | 2025 | 6 | 1.070 |
Why?
|
| Multiple Endocrine Neoplasia | 2 | 2025 | 22 | 1.060 |
Why?
|
| Hyperparathyroidism | 2 | 2025 | 24 | 1.060 |
Why?
|
| Genetic Predisposition to Disease | 15 | 2025 | 3425 | 1.020 |
Why?
|
| Carney Complex | 1 | 2025 | 2 | 0.940 |
Why?
|
| Medulloblastoma | 6 | 2019 | 385 | 0.800 |
Why?
|
| Cerebellar Neoplasms | 6 | 2019 | 321 | 0.740 |
Why?
|
| Wilms Tumor | 4 | 2025 | 120 | 0.710 |
Why?
|
| Germ-Line Mutation | 6 | 2025 | 375 | 0.570 |
Why?
|
| Whole Body Imaging | 1 | 2017 | 30 | 0.540 |
Why?
|
| Li-Fraumeni Syndrome | 1 | 2017 | 51 | 0.530 |
Why?
|
| Beckwith-Wiedemann Syndrome | 2 | 2024 | 16 | 0.420 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2017 | 738 | 0.400 |
Why?
|
| Child | 23 | 2025 | 26332 | 0.390 |
Why?
|
| Glutathione S-Transferase pi | 1 | 2012 | 25 | 0.380 |
Why?
|
| Radiotherapy | 1 | 2012 | 120 | 0.360 |
Why?
|
| Palatal Neoplasms | 1 | 2011 | 5 | 0.350 |
Why?
|
| Hearing Loss | 2 | 2017 | 211 | 0.350 |
Why?
|
| Connexins | 1 | 2011 | 64 | 0.340 |
Why?
|
| Hepatoblastoma | 2 | 2024 | 188 | 0.290 |
Why?
|
| Von Hippel-Lindau Tumor Suppressor Protein | 2 | 2025 | 34 | 0.280 |
Why?
|
| Oropharyngeal Neoplasms | 1 | 2011 | 269 | 0.270 |
Why?
|
| PTEN Phosphohydrolase | 2 | 2020 | 254 | 0.260 |
Why?
|
| DNA Methylation | 3 | 2019 | 1093 | 0.250 |
Why?
|
| Brain Neoplasms | 3 | 2024 | 1300 | 0.240 |
Why?
|
| Humans | 32 | 2025 | 131967 | 0.240 |
Why?
|
| Succinate Dehydrogenase | 1 | 2025 | 12 | 0.230 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2011 | 759 | 0.230 |
Why?
|
| Kidney Neoplasms | 3 | 2025 | 453 | 0.230 |
Why?
|
| Ribonuclease III | 2 | 2017 | 103 | 0.230 |
Why?
|
| DEAD-box RNA Helicases | 2 | 2017 | 162 | 0.220 |
Why?
|
| Practice Guidelines as Topic | 5 | 2025 | 1307 | 0.220 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2015 | 2863 | 0.210 |
Why?
|
| Retinoblastoma | 1 | 2025 | 87 | 0.210 |
Why?
|
| Retinal Neoplasms | 1 | 2025 | 74 | 0.210 |
Why?
|
| Mutation | 5 | 2020 | 6200 | 0.210 |
Why?
|
| Adolescent | 12 | 2025 | 21008 | 0.210 |
Why?
|
| Gadolinium | 1 | 2021 | 112 | 0.160 |
Why?
|
| DNA Polymerase II | 1 | 2019 | 19 | 0.160 |
Why?
|
| Poly-ADP-Ribose Binding Proteins | 1 | 2019 | 28 | 0.150 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2020 | 85 | 0.150 |
Why?
|
| Neurofibroma, Plexiform | 1 | 2018 | 8 | 0.140 |
Why?
|
| Neovascularization, Pathologic | 1 | 2020 | 234 | 0.140 |
Why?
|
| Cisplatin | 2 | 2017 | 286 | 0.140 |
Why?
|
| Vascular Malformations | 1 | 2020 | 109 | 0.140 |
Why?
|
| Neurofibromin 1 | 1 | 2018 | 57 | 0.140 |
Why?
|
| Genotype | 4 | 2022 | 2655 | 0.140 |
Why?
|
| Neurofibromatosis 1 | 1 | 2018 | 67 | 0.130 |
Why?
|
| Fumarate Hydratase | 1 | 2017 | 3 | 0.130 |
Why?
|
| Leiomyomatosis | 1 | 2017 | 7 | 0.130 |
Why?
|
| Proto-Oncogene Proteins c-ret | 1 | 2017 | 39 | 0.130 |
Why?
|
| Hamartoma Syndrome, Multiple | 1 | 2017 | 20 | 0.130 |
Why?
|
| Antigens, Nuclear | 1 | 2017 | 52 | 0.130 |
Why?
|
| p21-Activated Kinases | 1 | 2017 | 56 | 0.130 |
Why?
|
| Fibroma | 1 | 2017 | 29 | 0.130 |
Why?
|
| Child, Preschool | 10 | 2020 | 15066 | 0.130 |
Why?
|
| Thyroid Neoplasms | 1 | 2020 | 248 | 0.130 |
Why?
|
| Sacroiliac Joint | 1 | 2016 | 4 | 0.130 |
Why?
|
| Neurofibrosarcoma | 1 | 2016 | 6 | 0.130 |
Why?
|
| Sacrum | 1 | 2016 | 28 | 0.130 |
Why?
|
| Xeroderma Pigmentosum Group D Protein | 1 | 2016 | 19 | 0.130 |
Why?
|
| Spinal Nerve Roots | 1 | 2016 | 18 | 0.130 |
Why?
|
| Pelvic Bones | 1 | 2016 | 27 | 0.120 |
Why?
|
| Glioma | 1 | 2021 | 500 | 0.120 |
Why?
|
| Liver Neoplasms | 2 | 2024 | 1394 | 0.120 |
Why?
|
| Language Development Disorders | 1 | 2017 | 178 | 0.120 |
Why?
|
| Uterine Neoplasms | 1 | 2017 | 107 | 0.120 |
Why?
|
| Haploinsufficiency | 1 | 2017 | 265 | 0.120 |
Why?
|
| Adenoma | 1 | 2017 | 146 | 0.120 |
Why?
|
| DNA, Neoplasm | 1 | 2016 | 287 | 0.120 |
Why?
|
| Craniofacial Abnormalities | 1 | 2017 | 255 | 0.120 |
Why?
|
| Ear Diseases | 1 | 2015 | 23 | 0.120 |
Why?
|
| Infant | 8 | 2023 | 13332 | 0.110 |
Why?
|
| Population Surveillance | 1 | 2017 | 397 | 0.110 |
Why?
|
| Superoxide Dismutase | 1 | 2015 | 179 | 0.110 |
Why?
|
| Microcephaly | 1 | 2017 | 355 | 0.110 |
Why?
|
| Pinealoma | 1 | 2014 | 20 | 0.110 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2017 | 489 | 0.110 |
Why?
|
| Pineal Gland | 1 | 2014 | 21 | 0.110 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2017 | 602 | 0.100 |
Why?
|
| Female | 13 | 2020 | 71316 | 0.100 |
Why?
|
| Colorectal Neoplasms | 1 | 2019 | 639 | 0.100 |
Why?
|
| Young Adult | 5 | 2020 | 10108 | 0.100 |
Why?
|
| Neoplasm Proteins | 1 | 2017 | 677 | 0.100 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2017 | 1005 | 0.100 |
Why?
|
| Neuroectodermal Tumors, Primitive | 1 | 2012 | 45 | 0.090 |
Why?
|
| Genetic Testing | 3 | 2025 | 1101 | 0.090 |
Why?
|
| Diagnosis, Differential | 1 | 2017 | 1916 | 0.090 |
Why?
|
| Immunohistochemistry | 2 | 2012 | 1610 | 0.090 |
Why?
|
| Male | 12 | 2020 | 65357 | 0.090 |
Why?
|
| Connexin 26 | 1 | 2011 | 13 | 0.090 |
Why?
|
| Abnormalities, Multiple | 1 | 2017 | 974 | 0.090 |
Why?
|
| Nerve Tissue Proteins | 1 | 2017 | 1131 | 0.090 |
Why?
|
| Risk Factors | 4 | 2017 | 10998 | 0.080 |
Why?
|
| Disease-Free Survival | 1 | 2012 | 910 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2010 | 60 | 0.080 |
Why?
|
| Fatal Outcome | 1 | 2011 | 364 | 0.080 |
Why?
|
| Carcinoma, Small Cell | 1 | 2010 | 39 | 0.080 |
Why?
|
| Abdominal Neoplasms | 1 | 2010 | 31 | 0.080 |
Why?
|
| Thiolester Hydrolases | 1 | 2010 | 6 | 0.080 |
Why?
|
| I-kappa B Kinase | 1 | 2010 | 57 | 0.080 |
Why?
|
| Lymphatic Metastasis | 1 | 2011 | 433 | 0.080 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2012 | 1078 | 0.080 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2021 | 3928 | 0.080 |
Why?
|
| Skin Neoplasms | 1 | 2017 | 904 | 0.080 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2011 | 155 | 0.080 |
Why?
|
| Chromosomes, Human, X | 1 | 2010 | 155 | 0.080 |
Why?
|
| Genetic Variation | 1 | 2015 | 1566 | 0.070 |
Why?
|
| Biomarkers, Tumor | 1 | 2016 | 1618 | 0.070 |
Why?
|
| Transcription Factors | 1 | 2017 | 2442 | 0.070 |
Why?
|
| NF-kappa B | 1 | 2010 | 450 | 0.070 |
Why?
|
| Neoplasms | 1 | 2022 | 2965 | 0.070 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2010 | 643 | 0.070 |
Why?
|
| Retinoblastoma Binding Proteins | 1 | 2025 | 11 | 0.060 |
Why?
|
| DNA Mutational Analysis | 2 | 2019 | 803 | 0.060 |
Why?
|
| Phenotype | 3 | 2020 | 4531 | 0.060 |
Why?
|
| Australia | 1 | 2024 | 176 | 0.050 |
Why?
|
| Genetic Association Studies | 2 | 2018 | 835 | 0.050 |
Why?
|
| Adult | 3 | 2020 | 31734 | 0.050 |
Why?
|
| Respiratory Syncytial Viruses | 1 | 2003 | 153 | 0.050 |
Why?
|
| Fibroblast Growth Factors | 1 | 2003 | 169 | 0.050 |
Why?
|
| Patients | 1 | 2023 | 122 | 0.050 |
Why?
|
| Prognosis | 2 | 2020 | 4961 | 0.040 |
Why?
|
| DNA Mismatch Repair | 1 | 2019 | 45 | 0.040 |
Why?
|
| Follow-Up Studies | 2 | 2020 | 5298 | 0.040 |
Why?
|
| Leukocyte Count | 1 | 2019 | 249 | 0.040 |
Why?
|
| Germ Cells | 1 | 2019 | 204 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2017 | 5122 | 0.030 |
Why?
|
| Contrast Media | 1 | 2021 | 492 | 0.030 |
Why?
|
| Multiple Endocrine Neoplasia Type 2b | 1 | 2017 | 4 | 0.030 |
Why?
|
| Retrospective Studies | 3 | 2021 | 17703 | 0.030 |
Why?
|
| Middle Aged | 1 | 2017 | 28911 | 0.030 |
Why?
|
| Lymphocytes | 1 | 2019 | 359 | 0.030 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2017 | 116 | 0.030 |
Why?
|
| Larva | 1 | 2017 | 252 | 0.030 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 1 | 2017 | 93 | 0.030 |
Why?
|
| Antineoplastic Agents | 2 | 2017 | 1812 | 0.030 |
Why?
|
| Neutrophils | 1 | 2019 | 369 | 0.030 |
Why?
|
| Mass Screening | 1 | 2022 | 825 | 0.030 |
Why?
|
| Europe | 1 | 2017 | 373 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 2018 | 519 | 0.030 |
Why?
|
| Heterozygote | 1 | 2018 | 728 | 0.030 |
Why?
|
| Incidence | 1 | 2023 | 3352 | 0.030 |
Why?
|
| Medical Oncology | 1 | 2017 | 238 | 0.030 |
Why?
|
| CpG Islands | 1 | 2016 | 341 | 0.030 |
Why?
|
| Infant, Newborn | 2 | 2020 | 8604 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2019 | 1406 | 0.030 |
Why?
|
| Gene Editing | 1 | 2017 | 234 | 0.030 |
Why?
|
| Zebrafish | 1 | 2017 | 428 | 0.030 |
Why?
|
| CRISPR-Cas Systems | 1 | 2017 | 317 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2019 | 1457 | 0.030 |
Why?
|
| Mutation, Missense | 1 | 2018 | 932 | 0.030 |
Why?
|
| Family Health | 1 | 2014 | 251 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2016 | 1219 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2017 | 2963 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2019 | 1964 | 0.020 |
Why?
|
| Alleles | 1 | 2015 | 1713 | 0.020 |
Why?
|
| Yin-Yang | 1 | 2010 | 1 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2017 | 2483 | 0.020 |
Why?
|
| Ubiquitination | 1 | 2010 | 173 | 0.020 |
Why?
|
| Brain | 1 | 2021 | 3247 | 0.020 |
Why?
|
| HeLa Cells | 1 | 2010 | 694 | 0.020 |
Why?
|
| Translocation, Genetic | 1 | 2010 | 350 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2015 | 3453 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2010 | 419 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2010 | 659 | 0.020 |
Why?
|
| Texas | 1 | 2016 | 3629 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 1236 | 0.020 |
Why?
|
| Neurons | 1 | 2017 | 1998 | 0.020 |
Why?
|
| Cell Line | 1 | 2010 | 2607 | 0.010 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2003 | 23 | 0.010 |
Why?
|
| Virus Inactivation | 1 | 2003 | 10 | 0.010 |
Why?
|
| Dactinomycin | 1 | 2003 | 48 | 0.010 |
Why?
|
| Epidermal Growth Factor | 1 | 2003 | 116 | 0.010 |
Why?
|
| Bronchi | 1 | 2003 | 102 | 0.010 |
Why?
|
| Respiratory Sounds | 1 | 2003 | 80 | 0.010 |
Why?
|
| United States | 1 | 2017 | 11827 | 0.010 |
Why?
|
| Cell Survival | 1 | 2003 | 854 | 0.010 |
Why?
|
| Virus Replication | 1 | 2003 | 599 | 0.010 |
Why?
|
| Respiratory Syncytial Virus Infections | 1 | 2003 | 385 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 2003 | 900 | 0.010 |
Why?
|
| Animals | 1 | 2017 | 34460 | 0.010 |
Why?
|